BIOMAT Database Logo BIOMAT Database Logo

Highly purified insulins. 1978

K G Alberti, and M Nattrass

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007330 Insulin Antibodies Antibodies specific to INSULIN. Antibodies, Insulin
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K G Alberti, and M Nattrass
Highly purified insulins.
February 1979, Lancet (London, England),
K G Alberti, and M Nattrass
Letter: Highly purified insulins.
May 1976, Lancet (London, England),
K G Alberti, and M Nattrass
Letter: Highly purified insulins.
June 1976, Lancet (London, England),
K G Alberti, and M Nattrass
Purified insulins.
March 1977, Drug and therapeutics bulletin,
K G Alberti, and M Nattrass
[Highly purified insulins in the modern treatment of diabetes].
September 1975, Medizinische Klinik,
K G Alberti, and M Nattrass
Immunogenicity of highly purified bovine insulin: a comparison with conventional bovine and highly purified human insulins.
September 1985, Diabetologia,
K G Alberti, and M Nattrass
Approval of purified insulins.
November 1980, FDA drug bulletin,
K G Alberti, and M Nattrass
The new purified insulins.
June 1981, American pharmacy,
K G Alberti, and M Nattrass
Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins.
November 1988, Postgraduate medical journal,
K G Alberti, and M Nattrass
Dawn phenomenon and purified insulins.
July 1984, Lancet (London, England),
Copied contents to your clipboard!